[HTML][HTML] Nanovaccines: a game changing approach in the fight against infectious diseases
The field of nanotechnology has revolutionised global attempts to prevent, treat, and
eradicate infectious diseases in the foreseen future. Nanovaccines have proven to be a …
eradicate infectious diseases in the foreseen future. Nanovaccines have proven to be a …
Host–Pathogen interactions influencing zoonotic spillover potential and transmission in humans
Emerging infectious diseases of zoonotic origin are an ever-increasing public health risk
and economic burden. The factors that determine if and when an animal virus is able to spill …
and economic burden. The factors that determine if and when an animal virus is able to spill …
A SARS-CoV-2 vaccine candidate would likely match all currently circulating variants
The magnitude of the COVID-19 pandemic underscores the urgency for a safe and effective
vaccine. Many vaccine candidates focus on the Spike protein, as it is targeted by …
vaccine. Many vaccine candidates focus on the Spike protein, as it is targeted by …
Low genetic diversity may be an Achilles heel of SARS-CoV-2
JW Rausch, AA Capoferri… - Proceedings of the …, 2020 - National Acad Sciences
Scientists worldwide are racing to develop effective vaccines against severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2), the causative agent of the COVID-19 …
respiratory syndrome coronavirus 2 (SARS-CoV-2), the causative agent of the COVID-19 …
Nanovaccines against animal pathogens: The latest findings
Nowadays, safe and efficacious vaccines represent powerful and cost-effective tools for
global health and economic growth. In the veterinary field, these are undoubtedly key tools …
global health and economic growth. In the veterinary field, these are undoubtedly key tools …
Pathogenicity and Virulence of Ebolaviruses with Species-and Variant-specificity
Ebola virus (EBOV), belonging to the species Zaire ebolavirus in the genus Ebolavirus,
causes a severe febrile illness in humans with case fatality rates (CFRs) up to 90%. While …
causes a severe febrile illness in humans with case fatality rates (CFRs) up to 90%. While …
N123I mutation in the ALV-J receptor-binding domain region enhances viral replication ability by increasing the binding affinity with chNHE1
M Yu, Y Zhang, L Zhang, S Wang, Y Liu, Z Xu… - PloS …, 2024 - journals.plos.org
The subgroup J avian leukosis virus (ALV-J), a retrovirus, uses its gp85 protein to bind to the
receptor, the chicken sodium hydrogen exchanger isoform 1 (chNHE1), facilitating viral …
receptor, the chicken sodium hydrogen exchanger isoform 1 (chNHE1), facilitating viral …
[HTML][HTML] Comparison of epidemiological and clinical characteristics of COVID-19 patients with and without Wuhan exposure history in Zhejiang Province, China
J Lian, H Cai, S Hao, X Jin, X Zhang… - Journal of Zhejiang …, 2020 - ncbi.nlm.nih.gov
Background: A novel coronavirus called severe acute respiratory syndrome coronavirus 2
(SARS-CoV-2), first identified in Wuhan, China, has been rapidly spreading around the …
(SARS-CoV-2), first identified in Wuhan, China, has been rapidly spreading around the …
[HTML][HTML] Natural history of Ebola virus disease in rhesus monkeys shows viral variant emergence dynamics and tissue-specific host responses
Ebola virus (EBOV) causes Ebola virus disease (EVD), marked by severe hemorrhagic
fever; however, the mechanisms underlying the disease remain unclear. To assess the …
fever; however, the mechanisms underlying the disease remain unclear. To assess the …
Molecular characterization of the 2022 Sudan virus disease outbreak in Uganda
S Balinandi, S Whitmer, S Mulei, C Nassuna… - Journal of …, 2023 - Am Soc Microbiol
Uganda experienced five Ebola disease outbreaks caused by Bundibugyo virus (n= 1) and
Sudan virus (SUDV)(n= 4) from 2000 to 2021. On 20 September 2022, Uganda declared a …
Sudan virus (SUDV)(n= 4) from 2000 to 2021. On 20 September 2022, Uganda declared a …